Membranous Nephropathy Clinical Trials

43 clinical trials for Membranous Nephropathy across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Belimumab With Rituximab for Primary Membranous Nephropathy — RECRUITING · PHASE2
• Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX) — RECRUITING · PHASE3
• Immunopathological Analysis in a French National Cohort of Membranous Nephropathy — RECRUITING · NA
• Nephrotic Syndrome Study Network — RECRUITING
• NEPTUNE Match Study — RECRUITING · NA
• An Outcome Analysis of Primary Membranous Nephropathy — RECRUITING
• Autoreactive B Cells in Membranous Nephropathy — RECRUITING
• Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. — RECRUITING
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis — RECRUITING · PHASE2
• Impact of dapagliflozin for the regulation of immunological activity in Membranous Nephropathy — RECRUITING · PHASE3
• Raman Spectroscopy Diagnosis of Kidney Diseases — RECRUITING
• National Registry of Rare Kidney Diseases — RECRUITING
• KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis — RECRUITING
• Treatment with synthetic adrenocoticotropic hormone (ACTH) in patients with membranous nephropathy and high risk for renal failure. A pilot study. — ACTIVE_NOT_RECRUITING · PHASE2
• Obinutuzumab in Primary MN — COMPLETED · PHASE2
• Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial — NOT_YET_RECRUITING · PHASE2
• Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome — COMPLETED
• MOR202 for Refractory MN — COMPLETED · PHASE2
• Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy — COMPLETED
• Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy — TERMINATED · PHASE2
• A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases — NOT_YET_RECRUITING · PHASE1
• Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy — NOT_YET_RECRUITING · PHASE1
• Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy — COMPLETED · NA
• Effect of B-cell Depleting Therapies on PLA2R-specific B Cells in Patients With Membranous Nephropathy — COMPLETED · NA
• Study of Artificial Intelligence-based Personalized Rituximab Treatment Protocol in Membranous nephropathy — TERMINATED · PHASE3
• Omics of Rituximab-resistance — NOT_YET_RECRUITING
• Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy — TERMINATED · PHASE1
• An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases — ACTIVE_NOT_RECRUITING · PHASE1
• Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies — COMPLETED · PHASE2
• Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE) — COMPLETED · PHASE2
• IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients — NOT_YET_RECRUITING · PHASE1
• A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014) — TERMINATED · PHASE2
• Rescue Therapy with the Human Anti-CD38 Antibody MOR202 (felzartamab) in Patients with Membranous Nephropathy who Failed Anti-CD20 Target Therapy (MONET study) — OTHER · PHASE2
• Correlation and Clinical Utility of Urinary Biomarker in Membranous Glomerulonephritis — OTHER
• Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN) — TERMINATED · PHASE2
• Circulating Factors in Nephrotic Syndrome — NOT_YET_RECRUITING
• A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome — COMPLETED · PHASE1
• Adrenocorticotropic Hormone in Membranous Nephropathy — COMPLETED · PHASE4
• Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy — COMPLETED · PHASE3
• Rituximab in the Treatment of Idiopathic Membranous Nephropathy — COMPLETED · PHASE1
• Rituximab in Membranous Nephropathy — COMPLETED · PHASE2
• To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN) — COMPLETED · PHASE4
• The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy — COMPLETED · NA

Refine this search